Diltiazem Hydrochloride
Product Images NDC 0409-1171

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Diltiazem Hydrochloride (NDC 0409-1171). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Diltiazem 01)

Chemical structure diagram of Diltiazem Hydrochloride, showing the molecular arrangement with aromatic rings, sulfur, nitrogen, oxygen atoms, and functional groups including methoxy and acetoxy substituents, marked with the HCl component.*

FDA Label Image

Figure 1 (Diltiazem 02)

An instructional illustration showing a hand pressing down and turning the cap of a medication bottle, demonstrating how to open a child-resistant safety closure.*

FDA Label Image

Figure 2 (Diltiazem 03)

An instructional line drawing shows how to open a medication vial stopper by twisting the plastic cap counterclockwise and lifting it upward. The image emphasizes the motion of removing the cap to access the vial.*

FDA Label Image

Figure 3 (Diltiazem 04)

An instructional illustration showing two hands opening a bottle with a screw cap, revealing a clear liquid inside. The bottle has tubing attached at the bottom, indicating it is part of an intravenous (IV) infusion system. This likely depicts the preparation or use of an IV medication container.*

FDA Label Image

Figure 4 (Diltiazem 05)

An instructional black-and-white line drawing showing a hand pressing down on a cap or closure of a rectangular flexible container with two outlet ports at the bottom. This diagram likely illustrates how to operate or open the container, possibly for a liquid medication bag or IV bag, associated with Diltiazem Hydrochloride products from Hospira, Inc.*

FDA Label Image

Figure 5 (Diltiazem 06)

An instructional line drawing demonstrating the preparation or administration of intravenous medication involving a bag and tubing. The image shows one hand holding a bag with a port while the other hand manipulates a component, likely a medication vial or injection port, intended for use with the IV setup.*

FDA Label Image

Figure 6 (Diltiazem 07)

An instructional illustration depicting a hand handling a rectangular medical infusion bag with ports at the bottom for intravenous use. The diagram shows a person opening or adjusting the top sealing mechanism of the bag, commonly used for intravenous administration of solutions like Diltiazem Hydrochloride.*

FDA Label Image

Logo (Diltiazem 08)

FDA Label Image

Principal Display Panel (5 mL Vial Label)

Label for Diltiazem Hydrochloride 25 mg/5 mL injection in a 5 mL single-dose flipt top vial. The label indicates it is for direct intravenous bolus injection and continuous intravenous infusion. It is Rx only and labeled by Hospira Inc., Lake Forest, IL. Storage instructions specify 2° to 8°C (36° to 46°F).*

FDA Label Image

Principal Display Panel (5 mL Vial Carton)

Packaging label for Diltiazem Hydrochloride Injection 25 mg/5 mL (5 mg/mL) single-dose fliptop vials. The label states it is for direct intravenous bolus injection and continuous intravenous infusion. It includes storage instructions to store under refrigeration. The labeler is Hospira, Inc. The package contains 10 vials of 5 mL each and the NDC code is 0409-1171-01.*

FDA Label Image

Principal Display Panel (10 mL Vial Label)

Label for Diltiazem Hydrochloride Injection 50 mg/10 mL (5 mg/mL) in a 10 mL single-dose fliptop vial. It is labeled for direct intravenous bolus injection and continuous intravenous infusion. The label includes storage instructions to keep the product at 2° to 8°C (36° to 46°F). Labeler is Hospira, Inc.*

FDA Label Image

Principal Display Panel (10 mL Vial Carton)

Label for Diltiazem Hydrochloride Injection, 50 mg/10 mL (5 mg/mL) solution in single-dose fliptops. The label specifies use for direct intravenous bolus and continuous intravenous infusion. It includes storage instructions to keep under refrigeration and the labeler as Hospira, Inc. The package contains 10 vials of 10 mL each. The product is Rx only.*

FDA Label Image

Principal Display Panel (100 mg Vial Label)

Label for Diltiazem HCl for Injection, single-dose vial containing 100 mg/vial of sterile powder for continuous intravenous infusion. The label states 'Not For Bolus' use and includes storage instructions prior to reconstitution. Distributed by Hospira, Inc., Lake Forest, IL. The label includes lot and expiration date fields, a barcode, and an NDC number 0409-4350-13.*

FDA Label Image

Principal Display Panel (100 mg Vial Tray)

Packaging label for Diltiazem HCl for Injection 100 mg/vial sterile powder by Hospira, Inc. The label indicates the product is for continuous intravenous infusion and not for bolus use. It includes storage instructions and manufacturer location details. The package contains 10 single-dose ADD-Vantage vials.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.